HIND Latest Press Releases

-- February 24, 2026 --

Livechain Completes Acquisition of Senior, Secured Debt of Humanyze, An MIT Incubated, AI Enabled HR Analytics Company Business Wire 8:00 AM

-- February 18, 2026 --

Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity Business Wire 9:00 AM

-- February 11, 2026 --

Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months Business Wire 7:00 AM

-- February 2, 2026 --

Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results Business Wire 7:00 AM

-- January 27, 2026 --

Independent Analyst Values Vyome's VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study Business Wire 8:00 AM

-- December 8, 2025 --

Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval Business Wire 8:00 AM

-- November 25, 2025 --

Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program Business Wire 7:00 AM

-- November 18, 2025 --

Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing Business Wire 7:00 AM

-- November 4, 2025 --

Vyome Holdings Announces Results of Annual Shareholder Meeting Business Wire 9:04 AM

-- September 29, 2025 --

Vyome Holdings Acquires MIT AI Spinout Oculo Health Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software